Tumor-specific delivery of temozolomide to overcome resistance in GEP-NETs
Ali Azhdarinia, PhD
Finished Projects
Uncovering the cellular mechanisms that limit clinical application of PRRT
Susanne Kossatz, PhD
Understanding the genetic and cellular origins of carcinoid cancer
Ramesh Shivdasani, MD, PhD
Understanding the physiologically relevant functions of DAXX
Guillermina (Gigi) Lozano, PhD
Understanding the tumor suppressor activities of ATRX-DAXX through epigenomic profiling and animal models
Peter Lewis, PhD; C. David Allis, PhD
Unfolded protein response in NETs
Scott André Oakes, MD
uPAR-targeted PRRT: new radionuclide-based therapy
Andreas Kjaer, MD, PhD, DMSc